With the constant stresses endured in everyday life, it is no wonder society’s blood pressures are shooting through the roof as soon as the morning alarm rings. In the US alone, an estimated 50 million individuals are affected by increased blood pressure, 62% of which are associated with attributable risk factor for cerebrovascular disease. Despite these concerning statistics, less than 60% of identified individuals receive treatment for their hypertension and only about a third of the population achieve adequate control of blood pressure. Now, new research published by Charles DeCarli in Lancet Neurology aids in the push towards greater awareness of blood pressure levels even amongst the healthy middle-aged population.
As the population ages, it is universally acknowledged that some will succumb to the awful fate of Alzheimer’s Disease (AD), a neurological disorder that accounts for 60-80% of all cases of dementia. Characterized by a decline in cognitive and social functions and severe memory loss, AD affects nearly 35% of the population over 85 years of age. Histopathologically, markers of AD include the formation of senile plaques, caused by the extracellular accumulation of amyloid fibrils in the brain, and intraneuronal aggregates of neurofibrillary tangles with lead to progressive brain dysfunction.
It has been said that music can help heal the soul. Now this old saying has transferred its healing powers onto improving memory-based interventions for the Alzheimer’s disease patient. Currently, Alzheimer’s disease (AD) affects approximately 5.2 million Americans aged 65 years and older, a number that is expected to reach 7.7 million by 2030. The disease has significant detrimental effects on the functional quality of life of both the patients and their caregivers. Although there exists numerous studies examining potential disease modifying drugs to combat AD, the number of new individuals suffering from the disease continues to grow daily, generating great urgency to implement non-pharmacological interventions that may help to improve daily functioning and quality of life of AD patients in the years ahead.
The signs of aging can never seem to escape us: your eyes get puffier, your wrinkles lines extend in length, and the creases at the corners of your mouth deepen substantially. Soon, you remember a friend’s nonchalant remark that you seem to look angry all the time…even when you’re smiling. Perhaps you are angry, both angry and sad that your youthful vigilance has come and gone all too quickly. Thankfully, there may be one treatment available that can offer a boost to your spirits: a recent study published in the Journal of Psychiatric Research reported that single treatment of age lines with botulinium toxin A (BTX-A or BOTOX) may alleviate depressive symptoms in patients who do not improve sufficiently on previous medication.
- The Broken Mirror
- Surprising Role of Prions in Neurodegenerative Diseases